SEC penalises Sanofi for payments to government and private sector officials

Paris-based pharmaceutical company Sanofi has agreed to pay over $25 million to resolve FCPA charges brought by the SEC concerning conduct in Kazakhstan and the Middle East.

Get unlimited access to all Global Investigations Review content